An enhanced Prior Authorization program that resides behind an incumbent PBM. Cost savings are achieved through greater oversight of high cost medications.

The program highlights are:

• Protects the patient clinically
• No disruption for patient since we work directly with the prescribing doctor and PBM
• Protects the plan financially (typically reviewing 20% of drugs costing more than $2,500/mo.)
• Savings estimated at 10% of total drug spend
• No program fees; fees are contingent on approved savings